IDEAS home Printed from https://ideas.repec.org/a/wly/hlthec/v9y2000i5p397-409.html
   My bibliography  Save this article

Cost function estimation: the choice of a model to apply to dementia

Author

Listed:
  • Christian Kronborg Andersen

    (Institute of Public Health, Health Economics, University of Southern Denmark, Odense, Denmark)

  • Kjeld Andersen

    (Center for Dementia Research, Department of Psychiatry, Odense University Hospital, Odense, Denmark)

  • Per Kragh-Sørensen

    (Center for Dementia Research, Department of Psychiatry, Odense University Hospital, Odense, Denmark)

Abstract

Statistical analysis of cost data is often difficult because of highly skewed data resulting from a few patients who incur high costs relative to the majority of patients. When the objective is to predict the cost for an individual patient, the literature suggests that one should choose a regression model based on the quality of its predictions. In exploring the econometric issues, the objective of this study was to estimate a cost function in order to estimate the annual health care cost of dementia. Using different models, health care costs were regressed on the degree of dementia, sex, age, marital status and presence of any co-morbidity other than dementia. Models with a log-transformed dependent variable, where predicted health care costs were re-transformed to the unlogged original scale by multiplying the exponential of the expected response on the log-scale with the average of the exponentiated residuals, were part of the considered models. The root mean square error (RMSE), the mean absolute error (MAE) and the Theil U-statistic criteria were used to assess which model best predicted the health care cost. Large values on each criterion indicate that the model performs poorly. Based on these criteria, a two-part model was chosen. In this model, the probability of incurring any costs was estimated using a logistic regression, while the level of the costs was estimated in the second part of the model. The choice of model had a substantial impact on the predicted health care costs, e.g. for a mildly demented patient, the estimated annual health care costs varied from DKK 71-273 to DKK 90-940 (US$ 1=DKK 7) depending on which model was chosen. For the two-part model, the estimated health care costs ranged from DKK 44-714, for a very mildly demented patient, to DKK 197-840, for a severely demented patient. Copyright © 2000 John Wiley & Sons, Ltd.

Suggested Citation

  • Christian Kronborg Andersen & Kjeld Andersen & Per Kragh-Sørensen, 2000. "Cost function estimation: the choice of a model to apply to dementia," Health Economics, John Wiley & Sons, Ltd., vol. 9(5), pages 397-409.
  • Handle: RePEc:wly:hlthec:v:9:y:2000:i:5:p:397-409
    DOI: 10.1002/1099-1050(200007)9:5<397::AID-HEC527>3.0.CO;2-E
    as

    Download full text from publisher

    To our knowledge, this item is not available for download. To find whether it is available, there are three options:
    1. Check below whether another version of this item is available online.
    2. Check on the provider's web page whether it is in fact available.
    3. Perform a search for a similarly titled item that would be available.

    References listed on IDEAS

    as
    1. Manning, W. G. & Duan, N. & Rogers, W. H., 1987. "Monte Carlo evidence on the choice between sample selection and two-part models," Journal of Econometrics, Elsevier, vol. 35(1), pages 59-82, May.
    2. Paul Mcnamee & Barbara A. Gregson & Ken Wright & Debbie Buck & Claire H. Bamford & John Bond, 1998. "Estimation of a multiproduct cost function for physically frail older people," Health Economics, John Wiley & Sons, Ltd., vol. 7(8), pages 701-710.
    3. Andrew H. Briggs & David E. Wonderling & Christopher Z. Mooney, 1997. "Pulling cost-effectiveness analysis up by its bootstraps: A non-parametric approach to confidence interval estimation," Health Economics, John Wiley & Sons, Ltd., vol. 6(4), pages 327-340.
    4. Mullahy, John, 1998. "Much ado about two: reconsidering retransformation and the two-part model in health econometrics," Journal of Health Economics, Elsevier, vol. 17(3), pages 247-281, June.
    5. Leung, Siu Fai & Yu, Shihti, 1996. "On the choice between sample selection and two-part models," Journal of Econometrics, Elsevier, vol. 72(1-2), pages 197-229.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Negri­n, Miguel A. & Vázquez-Polo, Francisco-José, 2008. "Incorporating model uncertainty in cost-effectiveness analysis: A Bayesian model averaging approach," Journal of Health Economics, Elsevier, vol. 27(5), pages 1250-1259, September.
    2. Ebere Akobundu & Jing Ju & Lisa Blatt & C. Mullins, 2006. "Cost-of-Illness Studies," PharmacoEconomics, Springer, vol. 24(9), pages 869-890, September.
    3. Björn Stollenwerk & Thomas Welchowski & Matthias Vogl & Stephanie Stock, 2016. "Cost-of-illness studies based on massive data: a prevalence-based, top-down regression approach," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 17(3), pages 235-244, April.
    4. Francisco-José Polo & Miguel Negrín & Xavier Badía & Montse Roset, 2005. "Bayesian regression models for cost-effectiveness analysis," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 6(1), pages 45-52, March.
    5. Ahmadi, Sadra & Yeh, Chung-Hsing & Martin, Rodney & Papageorgiou, Elpiniki, 2015. "Optimizing ERP readiness improvements under budgetary constraints," International Journal of Production Economics, Elsevier, vol. 161(C), pages 105-115.
    6. Michele Cecchini & Franco Sassi, 2015. "Preventing Obesity in the USA: Impact on Health Service Utilization and Costs," PharmacoEconomics, Springer, vol. 33(7), pages 765-776, July.
    7. F. J. Vázquez-Polo & M. A. Negrín Hernández & B. González López-Valcárcel, 2005. "Using covariates to reduce uncertainty in the economic evaluation of clinical trial data," Health Economics, John Wiley & Sons, Ltd., vol. 14(6), pages 545-557.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:wly:hlthec:v:9:y:2000:i:5:p:397-409. See general information about how to correct material in RePEc.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Wiley-Blackwell Digital Licensing) or (Christopher F. Baum). General contact details of provider: http://www3.interscience.wiley.com/cgi-bin/jhome/5749 .

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service hosted by the Research Division of the Federal Reserve Bank of St. Louis . RePEc uses bibliographic data supplied by the respective publishers.